Pharmaceutical Technology, Feb 2, 2009 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Feb 2, 2009
Online Exclusive
Congress Approves Down Payment on Health Reform
By Jill Wechsler
The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.
An Analytical Technique with Special Resonance
By Susan J. Schniepp
A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.
Special Report
Illuminating Heavy Metals Testing
By Maribel Rios
USP <231> Heavy Metals is transitioning toward the incorporation of modern quantitative technologies, but there is still much to be resolved.
Peer-Reviewed Research
Formulation Development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride
By Renuka Mishra , Avani Amin
The authors formulated and developed taste-masked RDFs of cetirizine hydrochloride for patients who experience difficulty in swallowing the tablet dosage form of the drug.
The Rotation of Disinfectants Principle: True or False?
By Josť E. Martinez
The author defines sanitizers, disinfectants, and antibiotics, and examines the question of whether the rotation of disinfectants is scientifically warranted.
Ingredients Insider
Going Green in Pharmaceuticals
By Patricia Van Arnum
The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry.
Outsourcing Outlook
Strategic Service Partnerships Gain Momentum
By Jim Miller
Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.
Washington Report
Drug Prices Remain on the Cutting Board
By Jill Wechsler
Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.
Inside IPEC
Inside IPEC: Regulation for Excipients is Brewing Across the Atlantic
By Phil Taylor
Without any GMP guidelines for excipients in Europe, change can't come soon enough for some industry groups.
From The Editor
Whither FDA?
By Michelle Hoffman
FDA's role should not be overlooked as it has been in years past.
Quick Solutions
By Control, a senior compliance officer
GMP experts act fast to resolve some unusual and difficult problems.
There is No Such Thing as Zero Risk
By Peter H. Gough
To manage risk properly, industry must understand what it is and how to assess it
Report from: Romania
By Bibiana Campos-Seijo
The Romanian pharmacetuical market has grown significantly in recent years, but with stagnation on the horizon, a path forward is needed.
PharmTech Talk
Pharma Forecast
By Alexis Pellek
A recent reader poll focused on predictions for the industry's future.
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations
Pharma Capsules
Pharma Capsules
Brief pharmaceutical news items for February 2009.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here